CARCINOMA OF PANCREAS

CARCINOMA OF PANCREAS


CARCINOMA OF PANCREAS

  • Carcinoma of pancreas is the 4th leading cause of cancer in males.

  

  

RISK FACTORS-

  1. Demographic, environmental factor
  • Smoking/ tobacco
  • Obesity
  • Exposure to benzidine, DDT

     2. Molecular carcinogenesis

  • MC mutation- KRAS
  • MC inactivated tumour suppression gene- p16/ CDKN2A

     3. Genetic and medication factors-

  • Hereditary pancreatitis
  • Chronic pancreatitis
  • Peutz- Jegher’s syndrome (MC risk), Gardner’s syndrome
  • HNPCC
  • Ataxia telangiectasia
  • Familial breast- ovarian cancer syndrome
  • DM
  • Hemochromatosis

 

PATHOLOGY-

  • Periampullary refers to carcinoma arising from ampulla of Vater, duodenal mucosa or lower end of common bile duct.
  • MC tumour of pancreas is ductal adenocarcinoma with the most common site being the head of the gland.
  • Cystic tumours are mucinous and serous

a) Serous cystadenomas are benign seen in older women.

b) Mucinoustumors- have malignant potential. They are-

i) Mucinous cystic neoplasm (MCN)

  • Occurs in perimenopausal women
  • Present in pancreatic body or tail
  • It contains histologically ovarian type stroma

ii) Intraductal papillary mucinous neoplasm (IPMN)

  • Seen in old men
  • Common in pancreatic head
  • More tendency to be malignant.

   

  • Proliferative lesion in the pancreatic ducts –> invasive ductal adenocarcinoma termed as pancreatic intraepithelial neoplasm or PanIN.
  • Solid pseudopapillary tumours are rare malignancy seen in childbearing age women.

  

CLINICAL FEATURES-

  • MC site- head> body > tail
  • Seen in 6th to 7th decade
  • More common in males
  • Prognosis is bad
  • Nausea vomiting, weight loss and abdominal pain
  • Back pain (retroperitoneal infiltration)
  • Jaundice (MC)
  • Trousseau’s sign (thrombophelbitis migrans)
  • Migrating thrombophelibitis of the legs occurs in visceral malignancies
  • It is superficial and affects the leg veins
  • Anaemia
  • Hard, irregular fixed mass
  • Duodenal obstruction

  

INVESTIGATIONS-

  1. Pancreatic head tumors – contrast enhanced CT
  • ERCP is the most sensitive test for detecting pancreatic cancer but CT scan is the inv. of choice.

       2. USG- first IOC

  • Detects a tumor
  • Diagnois required prior to surgery

    3. CA 19- 9 (carbohydrate antigen)

  • Increase in 80% tumors
  • Tumour marker of pancreas to detect Pancreas carcinoma

     4. ERCP- small ampullary lesion

  • Double duct sign
  • Scrambled egg appearance

    5. Barium meal X-ray

  • Rose thorn appearance in hypotonic duodenography
  • Reverse 3 sign- periampullary carcinoma
  • Pad sign (widened C loop of duodenum) – carcinoma head

  

TREATMENT-

  1. Carcinoma head of pancreas (ampulla)-
  • Pylorous preserving pancreatico
  • Duodenectomy
  • Whipple’s procedures

     2. Carcinoma of body/ tail

  • Distal pancreatomy with en- bloc splenectomy
  1. Multifocal tumor- total pancreatectomy (main duct IMPN)
  2. Radiotherapy
  3. Gemcitabine + erlobinib- HER1/ EGFR tyrosine kinase inhibitor for metastatic disease
  • Stage wise survival after treatment-
a) Stage I and II- 16- 20 months
b) Stage III- 6- 10 months
c) Stage IV- 3- 6 months

 

Exam Important

RISK FACTORS-

  1. Demographic, environmental factor
  • Smoking/ tobacco
  • Obesity
  • Exposure to benzidine, DDT

     2. Molecular carcinogenesis

  • MC mutation- KRAS
  • MC inactivated tumour suppression gene- p16/ CDKN2A

     3. Genetic and medication factors-

  • Hereditary pancreatitis
  • Chronic pancreatitis
  • Peutz- Jegher’s syndrome (MC risk), Gardner’s syndrome
  • HNPCC
  • Ataxia telangiectasia
  • Familial breast- ovarian cancer syndrome
  • DM
  • Hemochromatosis
CLINICAL FEATURES-

  • MC site- head> body > tail
  • Seen in 6th to 7th decade
  • More common in males
  • Prognosis is bad
  • Nausea vomiting, weight loss and abdominal pain
  • Back pain (retroperitoneal infiltration)
  • Jaundice (MC)
  • Trousseau’s sign (thrombophelbitis migrans)
  • Migrating thrombophelibitis of the legs occurs in visceral malignancies
  • It is superficial and affects the leg veins
  • Anaemia
  • Hard, irregular fixed mass
  • Duodenal obstruction

 

INVESTIGATIONS-

  1. Pancreatic head tumors – contrast enhanced CT
  • ERCP is the most sensitive test for detecting pancreatic cancer but CT scan is the inv. of choice.

       2. USG- first IOC

  • Detects a tumor
  • Diagnois required prior to surgery
  • Stage wise survival after treatment-
a) Stage I and II- 16- 20 months
b) Stage III- 6- 10 months
c) Stage IV- 3- 6 months

 

Don’t Forget to Solve all the previous Year Question asked on CARCINOMA OF PANCREAS
Click Here to Start Quiz

Module Below Start Quiz

Leave a Reply

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support